R. Surabhi

P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer.

Swetha Raghavan, J. Biswal, J. Jeyaraman, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Mechanics of PAK1—A new molecular player in the arena of skin cancer

S. Rayala, G. Venkatraman, S. Beesetti, 2018, Journal of cellular physiology.

Transcriptional regulation of ataxia–telangiectasia and Rad3-related protein by activated p21-activated kinase-1 protects keratinocytes in UV-B-induced premalignant skin lesions

T. Oberyszyn, S. Rayala, G. Venkatraman, 2017, Oncogene.

KIBRA attains oncogenic activity by repressing RASSF1A

S. Rayala, G. Venkatraman, S. Sundaram, 2017, British Journal of Cancer.

Phosphorylation-Dependent Regulation of the DNA Damage Response of Adaptor Protein KIBRA in Cancer Cells

S. Rayala, G. Venkatraman, J. Kremerskothen, 2016, Molecular and Cellular Biology.

Threonine 209 phosphorylation on RUNX3 by Pak1 is a molecular switch for its dualistic functions

S. Rayala, S. Jagadeeshan, S. Srinivasan, 2016, Oncogene.

Molecular Mechanism of Regulation of MTA1 Expression by Granulocyte Colony-stimulating Factor*

S. Rayala, S. Jagadeeshan, G. Venkatraman, 2016, The Journal of Biological Chemistry.

Activation of oncogenic signaling kinase PAK1 by ionising radiation confers an aggressive phenotype in head and neck squamous cell carcinoma.

R. Surabhi, R. Pitani, Rayala Suresh Kumar, 2023, Cellular signalling.